Colcrys and Lidoderm drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Colcrys (colchicine) and Lidoderm (lidocaine). Common drug interactions include cyanosis among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Colcrys and Lidoderm. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Colcrys?

Colcrys has active ingredients of colchicine. It is often used in gout. eHealthMe is studying from 4,546 Colcrys users. Check the latest studies of Colcrys.

What is Lidoderm?

Lidoderm has active ingredients of lidocaine. It is often used in pain. eHealthMe is studying from 10,524 Lidoderm users. Check the latest studies of Lidoderm.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 26, 2026

35 people who take Colcrys and Lidoderm together, and have interactions are studied.

Colcrys and Lidoderm drug interactions.

What are the common drug interactions of Colcrys and Lidoderm, by gender? *:

female:

  1. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Dizziness
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Renal failure (kidney dysfunction)
  6. Dyspnoea (difficult or laboured respiration)
  7. Abdominal distension
  8. Fall
  9. Nausea (feeling of having an urge to vomit)
  10. Chronic kidney disease

male:

  1. Chronic kidney disease
  2. Dyspnoea (difficult or laboured respiration)
  3. Hypoacusis (loss of hearing)
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Nephropathy (damage to or disease of a kidney)
  6. Red blood cell count decreased
  7. Renal disorder (kidney disease)
  8. Renal impairment (severely reduced kidney function)
  9. Vomiting
  10. White blood cell count decreased

What are the common drug interactions of Colcrys and Lidoderm, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cough
  2. Diarrhoea
  3. Dyspnoea (difficult or laboured respiration)

50-59:

  1. Drug hypersensitivity
  2. Dyspepsia (indigestion)
  3. Dyspnoea (difficult or laboured respiration)
  4. Fall
  5. Fear of disease
  6. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  7. Hypertension (high blood pressure)
  8. Hypokalaemia (low potassium)
  9. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  10. Iron deficiency anaemia

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Facial bones fracture (bone fracture of face)
  4. Fall
  5. Gait disturbance
  6. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  7. Influenza
  8. Pain in extremity
  9. Red blood cell count decreased
  10. Renal impairment (severely reduced kidney function)

What are the existing conditions these people have? *

  1. High Blood Pressure: 10 people, 28.57%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 25.71%
  3. High Blood Cholesterol: 7 people, 20.00%
  4. Constipation: 6 people, 17.14%
  5. Diabetes: 6 people, 17.14%
  6. Muscle Spasms (muscle contraction): 5 people, 14.29%
  7. Stress And Anxiety: 5 people, 14.29%
  8. Hyperkalemia (damage to or disease of the kidney): 5 people, 14.29%
  9. Hypersensitivity: 5 people, 14.29%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 11.43%

* Approximation only. Some reports may have incomplete information.

Do you take Colcrys and Lidoderm?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Colcrys and Lidoderm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Colcrys:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lidoderm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Colcrys and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lidoderm and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on colchicine and lidocaine (the active ingredients of Colcrys and Lidoderm, respectively), and Colcrys and Lidoderm (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: